Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655129
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-04-23
Brief Title:
Intense Pulsed Light IPL Medical Device as Treatment for Patient Suffering From Skin Disorder
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Post Market Clinical Study of an Intense Pulsed Light IPL Medical Device as Treatment for Patient Suffering From Skin Disorder
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Anthelia
Brief Summary:
The first IPL device obtained United States Food and Drug Administration FDA clearance in 1995 for treatment of lower extremity telangiectasias Since then its favorable cost and versatility in contrast to many singlespectrum lasers has led to its rapid proliferation and use in a number of different clinical settings As described in the literature ANTHÉLIA medical device is intended to treat skin disorders
Excessive Hairiness Hirsutism Hypertrichosis
Vascular lesions Rosacea
Pigmented lesions Lentigo et melasma
Acne vulgaris
Excessive Hairiness Hirsutism Hypertrichosis
Vascular lesions Rosacea
Pigmented lesions Lentigo et melasma
Acne vulgaris
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None